Headquartered in King of Prussia, PA in the United States, Omnicare Clinical Research provides clinical development services to pharmaceutical, biotechnology and medical device companies through its office locations in 31 countries worldwide. As a premier Phase I-IV contract research organization, Omnicare Clinical Research features diverse therapeutic expertise and a comprehensive scope of clinical service offerings. Additionally, the company is an industry leader in geriatrics-focused drug studies. Omnicare Clinical Research focuses on providing clients with a superior drug development experience through strong project management, exceptional service and proactive solutions. The company is a subsidiary of Omnicare, Inc., a leading provider of pharmacy services to long-term care facilities and other chronic care settings comprising nearly 1.4 million beds in 47 states (NYSE: OCR).

 

Omnicare Clinical Research announced on 18 February 2008 that it has opened an office in Shanghai and another office in Beijing. The fully-staffed new facilities include professionals in Project Management, Clinical Trial Services, Regulatory Affairs and Business Development.